High Rates of Remission with the Initial Treatment of Oral Azacitidine Plus CHOP for Peripheral T-Cell Lymphoma (PTCL): Clinical Outcomes and Biomarker Analysis of a Multi-Center Phase II StudyJia Ruan, Leandro Cerchietti, Zhengming Chen et al.|Blood|2021Cited by 11
A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell LymphomasSarah C. Rutherford, Peter Martin, John N. Allan et al.|Blood|2020Cited by 8